|
1
|
Krebs MG, Metcalf RL, Carter L, Brady G,
Blackhall FH and Dive C: Molecular analysis of circulating tumour
cells - biology and biomarkers. Nat Rev Clin Oncol. 11:129–144.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lianidou ES: Circulating tumor cell
isolation: A marathon race worth running. Clin Chem. 60:287–289.
2014. View Article : Google Scholar
|
|
4
|
Plaks V, Koopman CD and Werb Z: Cancer.
Circulating tumor cells. Science. 341:1186–1188. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cristofanilli M, Budd GT, Ellis MJ,
Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ,
Terstappen LW, et al: Circulating tumor cells, disease progression,
and survival in metastatic breast cancer. N Engl J Med.
351:781–791. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
de Bono JS, Scher HI, Montgomery RB,
Parker C, Miller MC, Tissing H, Doyle GV, Terstappen LW, Pienta KJ
and Raghavan D: Circulating tumor cells predict survival benefit
from treatment in metastatic castration-resistant prostate cancer.
Clin Cancer Res. 14:6302–6309. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cohen SJ, Punt CJ, Iannotti N, Saidman BH,
Sabbath KD, Gabrail NY, Picus J, Morse M, Mitchell E, Miller MC, et
al: Relationship of circulating tumor cells to tumor response,
progression-free survival, and overall survival in patients with
metastatic colorectal cancer. J Clin Oncol. 26:3213–3221. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cristofanilli M: Circulating tumor cells,
disease progression, and survival in metastatic breast cancer.
Semin Oncol. 33(Suppl 9): S9–S14. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rhim AD, Mirek ET, Aiello NM, Maitra A,
Bailey JM, McAllister F, Reichert M, Beatty GL, Rustgi AK,
Vonderheide RH, et al: EMT and dissemination precede pancreatic
tumor formation. Cell. 148:349–361. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hou JM, Krebs MG, Lancashire L, Sloane R,
Backen A, Swain RK, Priest LJ, Greystoke A, Zhou C, Morris K, et
al: Clinical significance and molecular characteristics of
circulating tumor cells and circulating tumor microemboli in
patients with small-cell lung cancer. J Clin Oncol. 30:525–532.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fidler IJ: The relationship of embolic
homogeneity, number, size and viability to the incidence of
experimental metastasis. Eur J Cancer. 9:223–227. 1973. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lione A and Bosmann HB: Quantitative
relationship between volume of tumour cell units and their
intravascular survival. Br J Cancer. 37:248–253. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liotta LA, Kleinerman J and Saidel GM:
Quantitative relationships of intravascular tumor cells, tumor
vessels, and pulmonary metastases following tumor implantation.
Cancer Res. 34:997–1004. 1974.PubMed/NCBI
|
|
14
|
Liotta LA, Saidel MG and Kleinerman J: The
significance of hematogenous tumor cell clumps in the metastatic
process. Cancer Res. 36:889–894. 1976.PubMed/NCBI
|
|
15
|
Thompson SC: The colony forming efficiency
of single cells and cell aggregates from a spontaneous mouse
mammary tumour using the lung colony assay. Br J Cancer.
30:332–336. 1974. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Aceto N, Bardia A, Miyamoto DT, Donaldson
MC, Wittner BS, Spencer JA, Yu M, Pely A, Engstrom A, Zhu H, et al:
Circulating tumor cell clusters are oligoclonal precursors of
breast cancer metastasis. Cell. 158:1110–1122. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen JF, Ho H, Lichterman J, Lu YT, Zhang
Y, Garcia MA, Chen SF, Liang AJ, Hodara E, Zhau HE, et al:
Subclassification of prostate cancer circulating tumor cells by
nuclear size reveals very small nuclear circulating tumor cells in
patients with visceral metastases. Cancer. 121:3240–3251. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
de Wit S, van Dalum G, Lenferink AT, Tibbe
AG, Hiltermann TJ, Groen HJ, van Rijn CJ and Terstappen LW: The
detection of EpCAM(+) and EpCAM(−) circulating tumor cells. Sci
Rep. 5:122702015. View Article : Google Scholar
|
|
19
|
Meng S, Tripathy D, Frenkel EP, Shete S,
Naftalis EZ, Huth JF, Beitsch PD, Leitch M, Hoover S, Euhus D, et
al: Circulating tumor cells in patients with breast cancer
dormancy. Clin Cancer Res. 10:8152–8162. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Watanabe S: The metastasizability of tumor
cells. Cancer. 7:215–223. 1954. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Garvie WH and Matheson AB: The effect of
intravenous fluids on the development on experimental tumour
metastases: Their effect on tumour cell aggregation. Br J Cancer.
20:838–846. 1966. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Topal B, Roskams T, Fevery J and Penninckx
F: Aggregated colon cancer cells have a higher metastatic
efficiency in the liver compared with nonaggregated cells: An
experimental study. J Surg Res. 112:31–37. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Knisely WH and Mahaley MS Jr: Relationship
between size and distribution of spontaneous metastases and three
sizes of intravenously injected particles of VX2 carcinoma. Cancer
Res. 18:900–905. 1958.PubMed/NCBI
|
|
24
|
Peeters DJ, Brouwer A, Van den Eynden GG,
Rutten A, Onstenk W, Sieuwerts AM, Van Laere SJ, Huget P, Pauwels
P, Peeters M, et al: Circulating tumour cells and lung
microvascular tumour cell retention in patients with metastatic
breast and cervical cancer. Cancer Lett. 356B:872–879. 2015.
View Article : Google Scholar
|
|
25
|
Glaves D: Correlation between circulating
cancer cells and incidence of metastases. Br J Cancer. 48:665–673.
1983. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Stott SL, Hsu CH, Tsukrov DI, Yu M,
Miyamoto DT, Waltman BA, Rothenberg SM, Shah AM, Smas ME, Korir GK,
et al: Isolation of circulating tumor cells using a
microvortex-generating herringbone-chip. Proc Natl Acad Sci USA.
107:18392–18397. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Duda DG, Duyverman AM, Kohno M, Snuderl M,
Steller EJ, Fukumura D and Jain RK: Malignant cells facilitate lung
metastasis by bringing their own soil. Proc Natl Acad Sci USA.
107:21677–21682. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Upreti M, Jamshidi-Parsian A, Koonce NA,
Webber JS, Sharma SK, Asea AA, Mader MJ and Griffin RJ:
Tumor-endothelial cell three-dimensional spheroids: New aspects to
enhance radiation and drug therapeutics. Transl Oncol. 4:365–376.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hou JM, Krebs M, Ward T, Sloane R, Priest
L, Hughes A, Clack G, Ranson M, Blackhall F and Dive C: Circulating
tumor cells as a window on metastasis biology in lung cancer. Am J
Pathol. 178:989–996. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Friedlander TW, Ngo VT, Dong H,
Premasekharan G, Weinberg V, Doty S, Zhao Q, Gilbert EG, Ryan CJ,
Chen WT, et al: Detection and characterization of invasive
circulating tumor cells derived from men with metastatic
castration-resistant prostate cancer. Int J Cancer. 134:2284–2293.
2014. View Article : Google Scholar
|
|
31
|
Balasubramanian P, Lang JC, Jatana KR,
Miller B, Ozer E, Old M, Schuller DE, Agrawal A, Teknos TN, Summers
TA Jr, et al: Multiparameter analysis, including EMT markers, on
negatively enriched blood samples from patients with squamous cell
carcinoma of the head and neck. PLoS One. 7:e420482012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Brandt B, Junker R, Griwatz C, Heidl S,
Brinkmann O, Semjonow A, Assmann G and Zänker KS: Isolation of
prostate-derived single cells and cell clusters from human
peripheral blood. Cancer Res. 56:4556–4561. 1996.PubMed/NCBI
|
|
33
|
Molnar B, Ladanyi A, Tanko L, Sréter L and
Tulassay Z: Circulating tumor cell clusters in the peripheral blood
of colorectal cancer patients. Clin Cancer Res. 7:4080–4085.
2001.PubMed/NCBI
|
|
34
|
Wang ZP, Eisenberger MA, Carducci MA,
Partin AW, Scher HI and Ts'o PO: Identification and
characterization of circulating prostate carcinoma cells. Cancer.
88:2787–2795. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sarioglu AF, Aceto N, Kojic N, Donaldson
MC, Zeinali M, Hamza B, Engstrom A, Zhu H, Sundaresan TK, Miyamoto
DT, et al: A microfluidic device for label-free, physical capture
of circulating tumor cell clusters. Nat Methods. 12:685–691. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Vona G, Sabile A, Louha M, Sitruk V,
Romana S, Schütze K, Capron F, Franco D, Pazzagli M, Vekemans M, et
al: Isolation by size of epithelial tumor cells: A new method for
the immunomorphological and molecular characterization of
circulating tumor cells. Am J Pathol. 156:57–63. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Vona G, Estepa L, Béroud C, Damotte D,
Capron F, Nalpas B, Mineur A, Franco D, Lacour B, Pol S, et al:
Impact of cytomorphological detection of circulating tumor cells in
patients with liver cancer. Hepatology. 39:792–797. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Krebs MG, Hou JM, Sloane R, Lancashire L,
Priest L, Nonaka D, Ward TH, Backen A, Clack G, Hughes A, et al:
Analysis of circulating tumor cells in patients with non-small cell
lung cancer using epithelial marker-dependent and -independent
approaches. J Thorac Oncol. 7:306–315. 2012. View Article : Google Scholar
|
|
39
|
Adams AA, Okagbare PI, Feng J, Hupert ML,
Patterson D, Göttert J, McCarley RL, Nikitopoulos D, Murphy MC and
Soper SA: Highly efficient circulating tumor cell isolation from
whole blood and label-free enumeration using polymer-based
microfluidics with an integrated conductivity sensor. J Am Chem
Soc. 130:8633–8641. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Gleghorn JP, Pratt ED, Denning D, Liu H,
Bander NH, Tagawa ST, Nanus DM, Giannakakou PA and Kirby BJ:
Capture of circulating tumor cells from whole blood of prostate
cancer patients using geometrically enhanced differential
immunocapture (GEDI) and a prostate-specific antibody. Lab Chip.
10:27–29. 2010. View Article : Google Scholar
|
|
41
|
Mohamed H, Murray M, Turner JN and Caggana
M: Isolation of tumor cells using size and deformation. J
Chromatogr A. 1216:8289–8295. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Tan SJ, Yobas L, Lee GY, Ong CN and Lim
CT: Microdevice for the isolation and enumeration of cancer cells
from blood. Biomed Microdevices. 11:883–892. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Xu Y, Phillips JA, Yan J, Li Q, Fan ZH and
Tan W: Aptamer-based microfluidic device for enrichment, sorting,
and detection of multiple cancer cells. Anal Chem. 81:7436–7442.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zheng S, Lin H, Liu JQ, Balic M, Datar R,
Cote RJ and Tai YC: Membrane microfilter device for selective
capture, electrolysis and genomic analysis of human circulating
tumor cells. J Chromatogr A. 1162:154–161. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hou HW, Warkiani ME, Khoo BL, Li ZR, Soo
RA, Tan DS, Lim WT, Han J, Bhagat AA and Lim CT: Isolation and
retrieval of circulating tumor cells using centrifugal forces. Sci
Rep. 3:12592013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Harouaka RA, Zhou MD, Yeh YT, Khan WJ, Das
A, Liu X, Christ CC, Dicker DT, Baney TS, Kaifi JT, et al: Flexible
micro spring array device for high-throughput enrichment of viable
circulating tumor cells. Clin Chem. 60:323–333. 2014. View Article : Google Scholar
|
|
47
|
Cho EH, Wendel M, Luttgen M, Yoshioka C,
Marrinucci D, Lazar D, Schram E, Nieva J, Bazhenova L, Morgan A, et
al: Characterization of circulating tumor cell aggregates
identified in patients with epithelial tumors. Phys Biol.
9:0160012012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ge F, Zhang H, Wang DD, Li L and Lin PP:
Enhanced detection and comprehensive in situ phenotypic
characterization of circulating and disseminated heteroploid
epithelial and glioma tumor cells. Oncotarget. 6:27049–27064. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zhang Y, Wang F, Ning N, Chen Q, Yang Z,
Guo Y, Xu D, Zhang D, Zhan T and Cui W: Patterns of circulating
tumor cells identified by CEP8, CK and CD45 in pancreatic cancer.
Int J Cancer. 136:1228–1233. 2015. View Article : Google Scholar
|
|
50
|
Zamay GS, Kolovskaya OS, Zamay TN,
Glazyrin YE, Krat AV, Zubkova O, Spivak E, Wehbe M, Gargaun A,
Muharemagic D, et al: Aptamers selected to postoperative lung
adenocarcinoma detect circulating tumor cells in human blood. Mol
Ther. 23:1486–1496. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
King MR, Phillips KG, Mitrugno A, Lee TR,
de Guillebon AM, Chandrasekaran S, McGuire MJ, Carr RT,
Baker-Groberg SM, Rigg RA, et al: A physical sciences network
characterization of circulating tumor cell aggregate transport. Am
J Physiol Cell Physiol. 308:C792–C802. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Cheung KJ, Padmanaban V, Silvestri V,
Schipper K, Cohen JD, Fairchild AN, Gorin MA, Verdone JE, Pienta
KJ, Bader JS, et al: Polyclonal breast cancer metastases arise from
collective dissemination of keratin 14-expressing tumor cell
clusters. Proc Natl Acad Sci USA. 113:E854–E863. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Glinsky VV, Glinsky GV, Glinskii OV,
Huxley VH, Turk JR, Mossine VV, Deutscher SL, Pienta KJ and Quinn
TP: Intravascular metastatic cancer cell homotypic aggregation at
the sites of primary attachment to the endothelium. Cancer Res.
63:3805–3811. 2003.PubMed/NCBI
|
|
54
|
Geng Y, Chandrasekaran S, Hsu JW, Gidwani
M, Hughes AD and King MR: Phenotypic switch in blood: Effects of
pro-inflammatory cytokines on breast cancer cell aggregation and
adhesion. PLoS One. 8:e549592013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Fidler IJ: Immune stimulation-inhibition
of experimental cancer metastasis. Cancer Res. 34:491–498.
1974.PubMed/NCBI
|
|
56
|
Gasic GJ, Gasic TB, Galanti N, Johnson T
and Murphy S: Platelet-tumor-cell interactions in mice. The role of
platelets in the spread of malignant disease. Int J Cancer.
11:704–718. 1973. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Läubli H, Stevenson JL, Varki A, Varki NM
and Borsig L: L-selectin facilitation of metastasis involves
temporal induction of Fut7-dependent ligands at sites of tumor cell
arrest. Cancer Res. 66:1536–1542. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Küsters B, Kats G, Roodink I, Verrijp K,
Wesseling P, Ruiter DJ, de Waal RM and Leenders WP: Micronodular
transformation as a novel mechanism of VEGF-A-induced metastasis.
Oncogene. 26:5808–5815. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Borsig L, Wong R, Hynes RO, Varki NM and
Varki A: Synergistic effects of L- and P-selectin in facilitating
tumor metastasis can involve non-mucin ligands and implicate
leukocytes as enhancers of metastasis. Proc Natl Acad Sci USA.
99:2193–2198. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Molnar B, Floro L, Sipos F, Toth B, Sreter
L and Tulassay Z: Elevation in peripheral blood circulating tumor
cell number correlates with macroscopic progression in UICC stage
IV colorectal cancer patients. Dis Markers. 24:141–150. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Sugino T, Kusakabe T, Hoshi N, Yamaguchi
T, Kawaguchi T, Goodison S, Sekimata M, Homma Y and Suzuki T: An
invasion-independent pathway of blood-borne metastasis: A new
murine mammary tumor model. Am J Pathol. 160:1973–1980. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Ao Z, Shah SH, Machlin LM, Parajuli R,
Miller PC, Rawal S, Williams AJ, Cote RJ, Lippman ME, Datar RH, et
al: Identification of cancer-associated fibroblasts in circulating
blood from patients with metastatic breast cancer. Cancer Res.
75:4681–4687. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Yu M, Bardia A, Wittner BS, Stott SL, Smas
ME, Ting DT, Isakoff SJ, Ciciliano JC, Wells MN, Shah AM, et al:
Circulating breast tumor cells exhibit dynamic changes in
epithelial and mesenchymal composition. Science. 339:580–584. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Sharma D, Brummel-Ziedins KE, Bouchard BA
and Holmes CE: Platelets in tumor progression: A host factor that
offers multiple potential targets in the treatment of cancer. J
Cell Physiol. 229:1005–1015. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Lecharpentier A, Vielh P, Perez-Moreno P,
Planchard D, Soria JC and Farace F: Detection of circulating tumour
cells with a hybrid (epithelial/mesenchymal) phenotype in patients
with metastatic non-small cell lung cancer. Br J Cancer.
105:1338–1341. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Maddipati R and Stanger BZ: Pancreatic
cancer metastases harbor evidence of polyclonality. Cancer Discov.
5:1086–1097. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Au SH, Storey BD, Moore JC, Tang Q, Chen
YL, Javaid S, Sarioglu AF, Sullivan R, Madden MW, O'Keefe R, et al:
Clusters of circulating tumor cells traverse capillary-sized
vessels. Proc Natl Acad Sci USA. 113:4947–4952. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Fidler IJ and Talmadge JE: Evidence that
intravenously derived murine pulmonary melanoma metastases can
originate from the expansion of a single tumor cell. Cancer Res.
46:5167–5171. 1986.PubMed/NCBI
|
|
69
|
Zhao Q, Barclay M, Hilkens J, Guo X,
Barrow H, Rhodes JM and Yu LG: Interaction between circulating
galectin-3 and cancer-associated MUC1 enhances tumour cell
homotypic aggregation and prevents anoikis. Mol Cancer. 9:1542010.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Zhao Q, Guo X, Nash GB, Stone PC, Hilkens
J, Rhodes JM and Yu LG: Circulating galectin-3 promotes metastasis
by modifying MUC1 localization on cancer cell surface. Cancer Res.
69:6799–6806. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Yu LG, Andrews N, Zhao Q, McKean D,
Williams JF, Connor LJ, Gerasimenko OV, Hilkens J, Hirabayashi J,
Kasai K, et al: Galectin-3 interaction with Thomsen-Friedenreich
disaccharide on cancer-associated MUC1 causes increased cancer cell
endothelial adhesion. J Biol Chem. 282:773–781. 2007. View Article : Google Scholar
|
|
72
|
Labelle M, Begum S and Hynes RO: Direct
signaling between platelets and cancer cells induces an
epithelial-mesenchymal-like transition and promotes metastasis.
Cancer Cell. 20:576–590. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Wels J, Kaplan RN, Rafii S and Lyden D:
Migratory neighbors and distant invaders: Tumor-associated niche
cells. Genes Dev. 22:559–574. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Psaila B and Lyden D: The metastatic
niche: Adapting the foreign soil. Nat Rev Cancer. 9:285–293. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Phillips KG, Lee AM, Tormoen GW, Rigg RA,
Kolatkar A, Luttgen M, Bethel K, Bazhenova L, Kuhn P, Newton P, et
al: The thrombotic potential of circulating tumor microemboli:
Computational modeling of circulating tumor cell-induced
coagulation. Am J Physiol Cell Physiol. 308:C229–C236. 2015.
View Article : Google Scholar :
|
|
76
|
Denes V, Lakk M, Makarovskiy A, Jakso P,
Szappanos S, Graf L, Mandel L, Karadi I and Geck P: Metastasis
blood test by flow cytometry: In vivo cancer spheroids and the role
of hypoxia. Int J Cancer. 136:1528–1536. 2015. View Article : Google Scholar
|
|
77
|
Al-Mehdi AB, Tozawa K, Fisher AB, Shientag
L, Lee A and Muschel RJ: Intravascular origin of metastasis from
the proliferation of endothelium-attached tumor cells: A new model
for metastasis. Nat Med. 6:100–102. 2000. View Article : Google Scholar
|
|
78
|
Mu Z, Wang C, Ye Z, Austin L, Civan J,
Hyslop T, Palazzo JP, Jaslow R, Li B, Myers RE, et al: Prospective
assessment of the prognostic value of circulating tumor cells and
their clusters in patients with advanced-stage breast cancer.
Breast Cancer Res Treat. 154:563–571. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Jansson S, Bendahl PO, Larsson AM,
Aaltonen KE and Rydén L: Prognostic impact of circulating tumor
cell apoptosis and clusters in serial blood samples from patients
with metastatic breast cancer in a prospective observational
cohort. BMC Cancer. 16:4332016. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Mascalchi M, Falchini M, Maddau C,
Salvianti F, Nistri M, Bertelli E, Sali L, Zuccherelli S, Vella A,
Matucci M, et al: Prevalence and number of circulating tumour cells
and microemboli at diagnosis of advanced NSCLC. J Cancer Res Clin
Oncol. 142:195–200. 2016. View Article : Google Scholar
|
|
81
|
Giesing M, Suchy B, Driesel G and Molitor
D: Clinical utility of antioxidant gene expression levels in
circulating cancer cell clusters for the detection of prostate
cancer in patients with prostate-specific antigen levels of 4–10
ng/ml and disease prognostication after radical prostatectomy. BJU
Int. 105:1000–1010. 2010. View Article : Google Scholar
|
|
82
|
Choi JW, Kim JK, Yang YJ, Kim P, Yoon KH
and Yun SH: Urokinase exerts antimetastatic effects by dissociating
clusters of circulating tumor cells. Cancer Res. 75:4474–4482.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Wendel M, Bazhenova L, Boshuizen R,
Kolatkar A, Honnatti M, Cho EH, Marrinucci D, Sandhu A, Perricone
A, Thistlethwaite P, et al: Fluid biopsy for circulating tumor cell
identification in patients with early-and late-stage non-small cell
lung cancer: A glimpse into lung cancer biology. Phys Biol.
9:0160052012. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Reddy RM, Murlidhar V, Zhao L,
Grabauskiene S, Zhang Z, Ramnath N, Lin J, Chang AC, Carrott P,
Lynch W, et al: Pulmonary venous blood sampling significantly
increases the yield of circulating tumor cells in early-stage lung
cancer. J Thorac Cardiovasc Surg. 151:852–857. 2016. View Article : Google Scholar
|
|
85
|
Kats-Ugurlu G, Roodink I, de Weijert M,
Tiemessen D, Maass C, Verrijp K, van der Laak J, de Waal R, Mulders
P, Oosterwijk E, et al: Circulating tumour tissue fragments in
patients with pulmonary metastasis of clear cell renal cell
carcinoma. J Pathol. 219:287–293. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Loh J, Jovanovic L, Lehman M, Capp A,
Pryor D, Harris M, Nelson C and Martin J: Circulating tumor cell
detection in high-risk non-metastatic prostate cancer. J Cancer Res
Clin Oncol. 140:2157–2162. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Chang MC, Chang YT, Chen JY, Jeng YM, Yang
CY, Tien YW, Yang SH, Chen HL, Liang TY, Wang CF, et al: Clinical
significance of circulating tumor microemboli as a prognostic
marker in patients with pancreatic ductal adenocarcinoma. Clin
Chem. 62:505–513. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Long E, Ilie M, Bence C, Butori C, Selva
E, Lalvée S, Bonnetaud C, Poissonnet G, Lacour JP, Bahadoran P, et
al: High expression of TRF2, SOX10, and CD10 in circulating tumor
microemboli detected in metastatic melanoma patients. A potential
impact for the assessment of disease aggressiveness. Cancer Med.
5:1022–1030. 2016. View Article : Google Scholar : PubMed/NCBI
|
